Royalty pharma plc RPRX 深 滬
已收盤 10-10 16:00:00 美东时间
36.01
-0.130
-0.36%
華盛通- 最 高36.36
- 今 開36.32
- 成交量 203.96万股
- 最 低 35.945
- 昨 收 36.14
- 總市值 151.60亿
- 52周最高 37.78
- 市盈率 靜 18.83
- 換手率 0.48%
- 52周最低 23.39
- 委 比 70.50%
- 總股本 4.21亿
- 歷史最高 52.46
- 量 比 0.98
- 振 幅 1.15%
- 歷史最低 23.39
- 每 手 1
- 風險率 1.16%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Morgan Stanley Maintains Overweight on Royalty Pharma, Lowers Price Target to $54
Morgan Stanley analyst Terence Flynn maintains Royalty Pharma (NASDAQ:RPRX) with a Overweight and lowers the price target from $55 to $54.
10-11 01:40
Zenas BioPharma rises after Wedbush raises price target
Shares of Zenas BioPharma (NASDAQ:ZBIO) rose on Thursday after Wedbush raised its price target, pointing to the company’s expanding late-stage pipeline and successful asset in-licensing strategy. The ...
10-10 02:20
Zenas Biopharma Raises $120 Million To Secure Global Rights To Multiple Sclerosis Drug
Zenas BioPharma secures global rights to orelabrutinib in multiple sclerosis, expands autoimmune pipeline, and raises $120 million in private placement.
10-09 01:56
美股大行评级 | 潜在涨幅超31%！摩根大通维持通用汽车"超配"评级，目标价从60美元升至80美元
今日重点评级关注：Maxim Group：上调Adial Pharmaceuticals评级至"买入"，目标价1.5美元；BTIG：维持Climb Bio"买入"评级，目标价从7美元升至8美元
10-01 20:13
Goldman Sachs Initiates Coverage On Royalty Pharma with Buy Rating, Announces Price Target of $42
Goldman Sachs analyst Asad Haider initiates coverage on Royalty Pharma (NASDAQ:RPRX) with a Buy rating and announces Price Target of $42.
09-30 21:03
Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director
Royalty Pharma announced Dr. Ted W. Love as Lead Independent Director. With extensive biopharma experience, Love will continue to Chair the Nominating and Corporate Governance Committee. Love has served as BIO's Immediate Past Chairman and previously led Global Blood Therapeutics and Onyx Pharmaceuticals. Royalty Pharma, the largest biopharma royalties purchaser, aims to accelerate life sciences innovation. Royalty Pharma has assembled a portfol...
09-29 12:15
Royalty Pharma to Present at Bernstein’s 2nd Annual Healthcare Forum
Royalty Pharma will participate in a fireside chat at Bernstein’s 2nd Annual Healthcare Forum on September 23, 2025. The event will be webcast and available for viewing on Royalty Pharma’s website for at least 30 days. Royalty Pharma, founded in 1996, is the largest buyer of biopharmaceutical royalties and a leading funder of innovation in the biopharmaceutical industry. Their portfolio includes royalties on over 35 commercial products and 17 dev...
09-19 20:25
美股盘后 | 齐默巴奥米特控股涨3.96%，Sayona Mining Limited Unsponsored ADR涨2.81%
齐默巴奥米特控股涨3.96%；Sayona Mining Limited Unsponsored ADR涨2.81%；艺电涨2.67%
09-17 06:11
How Do Investors Really Feel About Royalty Pharma?
Royalty Pharma's (NYSE:RPRX) short interest as a percent of float has risen 18....
09-17 04:00
百济神州何以跃升A股医药公司市值第一？
市值站上5000亿元大关。 在2025年9月初，百济神州不但刷新自身纪录，也再次超越恒瑞医药，成为A股市值最高的医药公司。 上半年，百济神州营收达到175.1...
09-12 09:20
